Global Health · NSE: MEDANTA · BSE: 543654
Q1 FY27 results · Apr–Jun 2026
Global Health reported revenue from operations of ₹1,304.05 crore (up 26.5% from Q1 FY26) and net profit of ₹157.25 crore (down 1.1% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,304.05 | 1,030.84 | +26.5% | 1,159.05 | +12.5% |
| Other income | 22.16 | 20.46 | +8.3% | 36.74 | −39.7% |
| Total income | 1,326.21 | 1,051.29 | +26.2% | 1,195.79 | +10.9% |
| Profit before tax | 213.26 | 208.14 | +2.5% | 187.28 | +13.9% |
| Net profit for the period | 157.25 | 158.98 | −1.1% | 141.65 | +11.0% |
| Attributable to shareholders of the company | 158.73 | 159.01 | −0.2% | 143.99 | +10.2% |
| EPS, basic (₹) | 5.91 | 5.92 | −0.2% | 5.36 | +10.3% |
| Net margin (%) | 12.1 | 15.4 | 12.2 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,078.72 | 882.16 | +22.3% | 960.63 | +12.3% |
| Other income | 24.06 | 23.14 | +4.0% | 35.80 | −32.8% |
| Total income | 1,102.78 | 905.29 | +21.8% | 996.43 | +10.7% |
| Profit before tax | 183.11 | 198.25 | −7.6% | 163.47 | +12.0% |
| Net profit for the period | 137.31 | 151.96 | −9.6% | 124.13 | +10.6% |
| EPS, basic (₹) | 5.11 | 5.66 | −9.7% | 4.62 | +10.6% |
| Net margin (%) | 12.7 | 17.2 | 12.9 |
Consolidated
- Filed with BSE
- 30 Jul 2026, 15:58 IST
- Board meeting
- 30 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Jul 2026, 15:58 IST
- Board meeting
- 30 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE